Skip to content

Wave Life Sciences WVE Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$183.59M+10.2%-$204.38M
$3.41M-1.0%$3.44M-1.8%$3.5M-2.6%$3.6M-3.6%$3.73M-4.3%
$29.08M+16.5%$24.97M+19.7%$20.87M+16.4%$17.92M+17.8%$15.21M+15.8%
-$184.01M+1.9%-$187.49M+5.0%-$197.37M+0.9%-$199.18M-10.3%-$180.63M-19.6%
$992K+38.0%$719K-10.7%$805K-14.4%$940K+37.0%$686K-26.9%
-$992K-38.0%-$719K+10.7%-$805K+14.4%-$940K-37.0%-$686K+26.9%
$486.61M-0.3%$488.24M+485%$83.52M-67.2%$254.58M+4.5%$243.54M-4.1%
$301.56M+0.5%$300.04M+384%-$105.82M-267%$63.43M-10.7%$71.07M-35.8%
-$185M+1.7%-$188.21M+5.0%-$198.17M+1.0%-$200.12M-10.4%-$181.32M-19.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Wave Life Sciences generate?
Wave Life Sciences (WVE) generated -$184.0M in operating cash flow over the trailing twelve months.
What is Wave Life Sciences's free cash flow?
After $992.0K of capital expenditures, Wave Life Sciences's free cash flow was -$185.0M over the trailing twelve months, down 2.0% year over year.
Where does Wave Life Sciences's cash flow data come from?
Every line is extracted from Wave Life Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.